Valuation: PharmaEssentia Corporation

Market Cap 530B 16.05B 14.39B 13.26B 12.04B 22.8B 1,505B 23.43B 159B 63.27B 806B 60.22B 58.94B 2,548B P/E 2026 *
48.6x
P/E 2027 * 30.1x
Enterprise Value 507B 15.35B 13.77B 12.69B 11.52B 21.8B 1,439B 22.41B 152B 60.52B 771B 57.61B 56.38B 2,437B EV / Sales 2026 *
18.7x
EV / Sales 2027 * 12x
Free-Float
79.23%
Yield 2026 *
0.31%
Yield 2027 * 0.18%
1 day-6.57%
1 week+7.56%
Current month+7.56%
1 month+7.11%
3 months+3.23%
6 months+96.12%
Current year+202.10%
1 week 1,075
Extreme 1075
1,390
1 month 1,075
Extreme 1075
1,390
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 81.64
Extreme 81.640947
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 2016-12-31
Director of Finance/CFO - 2015-10-13
President - 2015-06-24
Director TitleAgeSince
Director/Board Member - 2000-05-08
Chairman - 2012-09-23
Director/Board Member - 2015-05-28
Change 5-day change 1-year change 3-year change Capi.($)
-6.57%+7.56%+183.41%+320.74% 17.29B
+0.01%+8.40%+58.48%+69.01% 68.22B
+1.22%+9.56%+15.97%+90.23% 59.82B
+0.24%+1.35%+23.78%+97.55% 56.07B
+0.84%+18.85%+28.17%+111.91% 47.67B
-1.65%+4.90%+29.29%+40.56% 45.95B
-4.88%-1.66%+204.48%+869.05% 43.29B
-3.33%+5.73%+23.28%+47.32% 35.66B
-2.19%-3.71%+90.94%+66.33% 34.73B
+1.87%+14.38%-37.76%+402.99% 25.47B
Average -1.40%+5.05%+62.00%+211.57% 43B
Weighted average by Cap. -0.94%+5.28%+55.32%+184.71%

Financials

2026 *2027 *
Net sales 27.07B 819M 734M 677M 615M 1.16B 76.78B 1.2B 8.1B 3.23B 41.14B 3.07B 3.01B 130B 41.5B 1.26B 1.13B 1.04B 942M 1.78B 118B 1.83B 12.42B 4.95B 63.07B 4.71B 4.61B 199B
Net income 10.52B 318M 285M 263M 239M 452M 29.85B 465M 3.15B 1.26B 15.99B 1.19B 1.17B 50.55B 17.96B 543M 487M 449M 408M 772M 50.95B 793M 5.38B 2.14B 27.3B 2.04B 2B 86.29B
Net Debt -23.05B -697M -625M -576M -523M -990M -65.37B -1.02B -6.9B -2.75B -35.02B -2.62B -2.56B -111B -34.24B -1.04B -929M -856M -777M -1.47B -97.12B -1.51B -10.25B -4.08B -52.03B -3.89B -3.8B -164B
Projected Income Statement - Annual - PharmaEssentia Corporation
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
26-11-09 NT$1,280.00 -6.57% 6,932,753
26-11-09 NT$1,370.00 +7.87% 5,627,041
26-11-06 NT$1,270.00 +7.17% 7,197,762
26-11-05 NT$1,185.00 -5.20% 3,513,424
26-11-04 NT$1,250.00 +2.04% 3,877,750
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - PharmaEssentia Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,280.00TWD
Average target price
1,437.27TWD
Spread / Average Target
+12.29%
  1. Stock Market
  2. Stocks
  3. 6446 Stock